Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01076699
Recruitment Status : Suspended (recruiting/enrolling participants has halted prematurely but potentially will resume Oct)
First Posted : February 26, 2010
Last Update Posted : July 19, 2010
Sponsor:
Information provided by:
Revogenex, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 2010
Estimated Study Completion Date : March 2011